Molina Healthcare Q3 2026 net income drops 52% year over year to $38 million
MOH•Molina Healthcare’s third-quarter 2026 GAAP net income fell 52% year over year to $38 million, while premium revenue declined to $10.46 billion. The company targets 2026 GAAP earnings of at least $2.38 per diluted share and expects approximately $42 billion in premium revenue.
1. Quarterly results
Molina Healthcare’s third-quarter 2026 GAAP net income fell 52% year over year to $38 million, mainly due to higher consolidated MCR. Premium revenue declined to $10.46 billion, reflecting lower Medicaid and Marketplace membership, partially offset by rate updates.
2. Cash flow and guidance
For the first nine months of 2026, operating cash flow swung to an inflow of $629 million, mainly due to lower government receivable and payable settlements. Full-year guidance targets GAAP earnings of at least $2.38 per diluted share, with premium revenue unchanged at approximately $42 billion.
3. Medicare Advantage exit
The company will exit its traditional Medicare Advantage Prescription Drug product for 2027.
